ArticleACS medicinal chemistry letters2019

Discovery of Novel Retigabine Derivatives as Potent KCNQ4 and KCNQ5 Channel Agonists with Improved Specificity.

Lei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.